Clinical use of High-Dose Neuroleptics
- 2 January 1994
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 164 (1) , 94-96
- https://doi.org/10.1192/bjp.164.1.94
Abstract
There has been increasing public concern about the risks of high-dose antipsychotic (neuroleptic) treatment, arising in part from an, as yet unproven, association between high-dose treatment and death in a small minority of patients. The clinical issues related to the use of neuroleptics in doses exceeding the maximum recommended in theBritish National Formulary(BNF) were discussed at the Psychopharmacology Subcommittee. When, if ever, should the recommended doses be exceeded?Keywords
This publication has 16 references indexed in Scilit:
- Rapid TranquillisationThe British Journal of Psychiatry, 1992
- A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in FinlandActa Psychiatrica Scandinavica, 1991
- Dosage of Haloperidol for SchizophreniaArchives of General Psychiatry, 1991
- Life-Threatening Ventricular Arrhythmia (Torsades de Pointes) after Haloperidol OverdoseHuman & Experimental Toxicology, 1991
- A Controlled Dose Comparison of Haloperidol in Newly Admitted Schizophrenic PatientsArchives of General Psychiatry, 1990
- Rapid Tranquilization: A ReevaluationNeuropsychobiology, 1989
- High Potency Neuroleptics and Violence in SchizophrenicsJournal of Nervous & Mental Disease, 1988
- Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of PsychosesArchives of General Psychiatry, 1988
- Iatrogenic torsade de pointes induced by thioridazineBiological Psychiatry, 1987
- Treatment of SchizophreniaSchizophrenia Bulletin, 1987